Home » Stocks » NVST

Envista Holdings Corporation (NVST)

Stock Price: $35.76 USD 0.57 (1.62%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 5.71B
Revenue (ttm) 2.27B
Net Income (ttm) -19.00M
Shares Out 159.70M
EPS (ttm) 1.60
PE Ratio 22.38
Forward PE 20.92
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $35.76
Previous Close $35.19
Change ($) 0.57
Change (%) 1.62%
Day's Open 35.06
Day's Range 34.42 - 35.99
Day's Volume 2,759,454
52-Week Range 11.91 - 35.99

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 1 week ago

BREA, Calif., Jan. 5, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the JP Morgan Healthcare Conference on Mon...

Zacks Investment Research - 1 month ago

Is Envista Holdings (NVST) a great pick from the value investor's perspective right now? Read on to know more.

PRNewsWire - 2 months ago

BREA, Calif., Nov. 10, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Wolfe Research Virtual Healthcare Con...

Seeking Alpha - 2 months ago

Envista Holdings went public in September 2019. The firm is separating from parent company Danaher and provides dental equipment and products worldwide.

Seeking Alpha - 2 months ago

Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Envista (NVST) delivered earnings and revenue surprises of 433.33% and 25.79%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 2 months ago

Shares of Envista Holdings (NYSE:NVST) moved higher by 4.29% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 2.13% over the past y...

PRNewsWire - 2 months ago

BREA, Calif., Oct. 29, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2020. For the third quarter, the Company's net income was $3...

Zacks Investment Research - 2 months ago

Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRNewsWire - 3 months ago

BREA, Calif., Oct. 14, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2020 on Thursday, October 29, 2020. Envist...

PRNewsWire - 4 months ago

BREA, Calif., Aug. 31, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2020 Global Healthcare Conferen...

InvestorPlace - 5 months ago

These 5 healthcare stocks look like the sector's best, with downside protection and room for price appreciation even if the market falters.

Other stocks mentioned: BHC, BMY, COO, MDT
InvestorPlace - 5 months ago

Many dentists went out of commission amid the novel coronavirus, but as they open back up, consider these dental stocks to buy. The post 7 Dental Stocks to Buy for Long-Term Gains appeared f...

Other stocks mentioned: DDD, HSIC, PDCO, PG, SDC, XRAY
Seeking Alpha - 5 months ago

Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q2 2020 Results - Earnings Call Transcript

PRNewsWire - 5 months ago

BREA, Calif., July 21, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2020 on Thursday, July 30, 2020.

Market Watch - 7 months ago

Amid a weeks-long rally in stocks, some investors may already have forgotten how painful it was when the market crashed in late February and March.

Other stocks mentioned: AEP, CTAS, FTV, GPN, HLT, HUM, IR, KDP, MAR, NXPI, PNC, SYK, UNH, YUM
PRNewsWire - 7 months ago

BREA, Calif., May 26, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will virtually participate in the Stifel 2020 Jaws & Paws Conf...

Seeking Alpha - 7 months ago

Taking the long view, NVST looks attractive, as a defensive business should hold up once some semblance of normalcy returns.

PRNewsWire - 7 months ago

BREA, Calif., May 18, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the pricing of its offering of $450,000,000 aggregate principal amount of 2.375% convertibl...

PRNewsWire - 7 months ago

BREA, Calif., May 18, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced its intention to offer, subject to market and other conditions, $400,000,000 aggregate prin...

Seeking Alpha - 8 months ago

Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Envista Holdings (NVST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 8 months ago

Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Seeking Alpha - 11 months ago

Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q4 2019 - Earnings Call Transcript

The Motley Fool - 11 months ago

These two dental products companies battle for investors’ attention. Which stock is more attractive?

Other stocks mentioned: ALGN
Zacks Investment Research - 1 year ago

NVST vs. GNNDY: Which Stock Is the Better Value Option?

About NVST

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures and markets dental products in the United States and internationally. The company operates in two segment, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare systems... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Sep 18, 2019
CEO
Amir Aghdaei
Employees
12,500
Stock Exchange
NYSE
Ticker Symbol
NVST
Full Company Profile

Financial Performance

In 2019, NVST's revenue was $2.75 billion, a decrease of -3.27% compared to the previous year's $2.84 billion. Earnings were $217.60 million, a decrease of -5.68%.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for NVST is 36.55, which is an increase of 2.21% from the latest price.

Price Target
$36.55
(2.21% upside)